首页> 外文期刊>Photodiagnosis and Photodynamic Therapy >Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma
【24h】

Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma

机译:铁螯合促进5-氨基硫脲酸基对口腔舌鳞状细胞癌的光动力学疗法

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Oral tongue squamous cell carcinoma (OTSCC) is the most common malignancy of the oral cavity. Photodynamic therapy (PDT) has become a clinically promising approach for early stage OTSCC treatment. 5-Aminolaevulinic acid (5-ALA) is a precursor of protoporphyrin IX (PpIX) and has been applied for PDT of cancer. However, the accumulated PpIX in 5-ALA-treated cancer cells will be further transformed into heme through ferrous iron insertion under ferrochelatase catalysis. Theoretically, iron chelation can enhance the intracellular accumulation of PpIX and thus promote 5-ALA-based PDT. Here, an iron chelator deferasirox (DFX) was used to investigate synergistic suppression effects of 5-ALA-based PDT and iron chelation on OTSCC.Methods: In OTSCC SCC-25 cells, the enhancing effect of DFX on 5-ALA-mediated accumulation of PpIX was firstly assessed. After laser irradiation (635 nm, 200 mW/cm(2) and 2 min), the synergistic cytotoxicity and apoptosis-inducing effect of 5-ALA and DFX were evaluated in SCC-25 cells, and the apoptosis mechanism was further investigated by monitoring the change of mitochondrial membrane potential and observing the subcellular localization of cytochrome c (Cyt c). In SCC-25 tumor-bearing mice, the synergistic suppression effects of 5-ALA-based PDT and DFX on tumor growth and tumor angiogenesis were investigated after laser irradiation on the tumor (635 nm, 150 mW/cm(2) and 10 min).Results: In SCC-25 cells, DFX showed strong iron chelation effect and enhanced 5-ALA-mediated intracellular accumulation of PpIX by 2-3 folds. After laser irradiation (635 nm, 200 mW/cm(2) and 2 min), 5-ALA combined with DFX exhibited significant synergistic effects on cytotoxicity and cell apoptosis. In the treated cells, the damage of mitochondrial membrane and the release of Cyt c from mitochondria to cytoplasm were observed distinctly, indicating the activation of mitochondria-related signal pathway. In SCC-25 tumor-bearing mice, tumor growth and tumor angiogenesis were both notably suppressed by combination treatment of 5-ALA with laser irradiation and DFX. Meanwhile, no obvious toxic injuries were visible in histological examination of major organs in the treated mice.Conclusions: 5-ALA-based PDT combined with iron chelation synergistically inhibited the growth of OTSCC. Hence it can be seen that this combination therapy may represent a promising strategy for clinical treatment of OTSCC and other cancers.
机译:背景:口腔舌鳞状细胞癌(OTSCC)是口腔最常见的恶性肿瘤。光动力疗法(PDT)已成为早期OTSCC治疗的临床前景方法。 5-氨基乙酰乙酰丙酸(5-ALA)是原生霉素IX(PPIX)的前体,已应用于癌症的PDT。然而,通过铁酸盐酶催化在铁酸溶酶催化下,将进一步将5 alA处理的癌细胞中的累积PPIX进一步转化为血红素。从理论上讲,铁螯合可以增强PPIX的细胞内积累,从而促进基于5 alA的PDT。这里,使用铁螯合剂脱铁司索(DFX)来研究OTSCC上的5 Ala基PDT和铁螯合物的协同抑制作用:在ototscc scc-25细胞中,Dfx对5-Ala介导的积累的增强作用PPIX首先评估了。激光照射(635nm,200mW / cm(2)和2分钟)后,在SCC-25细胞中评估了5-ALA和DFX的协同细胞毒性和凋亡诱导效果,并通过监测进一步研究了凋亡机制线粒体膜电位的变化和观察细胞色素C(CYT C)的亚细胞定位。在SCC-25携带肿瘤小鼠中,在肿瘤激光照射后,研究了肿瘤生长和肿瘤血管生成对肿瘤生长和肿瘤血管生成的协同抑制作用(635nm,150mW / cm(2)和10分钟)。结果:在SCC-25细胞中,DFX显示出强的铁螯合效应,并增强5-Ala介导的PPIX细胞内积聚2-3倍。激光照射(635nm,200mM / cm(2)和2分钟)后,5 - Ala与DFX结合表现出对细胞毒性和细胞凋亡的显着协同作用。在处理过的细胞中,明显地观察到线粒体膜的损伤和从线粒体到细胞质的细胞c的释放,表明线粒体相关信号途径的激活。在SCC-25肿瘤患者中,肿瘤生长和肿瘤血管生成均通过用激光照射和DFX的组合处理来尤其抑制5 ALA。同时,在处理过的小鼠中的主要器官的组织学检查中没有明显有毒损伤。结合:5 - Ala的PDT与铁螯合合并协同抑制ΔCC的生长。因此,可以看出,这种联合治疗可以代表对ΔCC和其他癌症的临床治疗的有希望的策略。

著录项

  • 来源
    《Photodiagnosis and Photodynamic Therapy》 |2020年第9期|101907.1-101907.10|共10页
  • 作者单位

    Tianjin Med Univ Sch Pharm Tianjin 300070 Peoples R China|Tianjin Med Univ Tianjin Key Lab Technol Enabling Dev Clin Therape Tianjin 300070 Peoples R China;

    Tianjin Med Univ Sch Pharm Tianjin 300070 Peoples R China|Tianjin Med Univ Tianjin Key Lab Technol Enabling Dev Clin Therape Tianjin 300070 Peoples R China;

    Tianjin Med Univ Sch Dent 22 Qixiangtai Rd Tianjin 300070 Peoples R China|Tianjin Med Univ Hosp Stomatol 22 Qixiangtai Rd Tianjin 300070 Peoples R China;

    Tianjin Med Univ Sch Dent 22 Qixiangtai Rd Tianjin 300070 Peoples R China|Tianjin Med Univ Hosp Stomatol 22 Qixiangtai Rd Tianjin 300070 Peoples R China;

    Tianjin Med Univ Sch Dent 22 Qixiangtai Rd Tianjin 300070 Peoples R China|Tianjin Med Univ Hosp Stomatol 22 Qixiangtai Rd Tianjin 300070 Peoples R China;

    Tianjin Med Univ Sch Dent 22 Qixiangtai Rd Tianjin 300070 Peoples R China|Tianjin Med Univ Hosp Stomatol 22 Qixiangtai Rd Tianjin 300070 Peoples R China;

    Tianjin Med Univ Sch Dent 22 Qixiangtai Rd Tianjin 300070 Peoples R China|Tianjin Med Univ Hosp Stomatol 22 Qixiangtai Rd Tianjin 300070 Peoples R China;

    Tianjin Med Univ Sch Pharm Tianjin 300070 Peoples R China|Tianjin Med Univ Tianjin Key Lab Technol Enabling Dev Clin Therape Tianjin 300070 Peoples R China;

    Tianjin Med Univ Sch Dent 22 Qixiangtai Rd Tianjin 300070 Peoples R China|Tianjin Med Univ Hosp Stomatol 22 Qixiangtai Rd Tianjin 300070 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    5-Aminolaevulinic acid; Deferasirox; Photodynamic therapy; Iron chelation; Oral tongue squamous cell carcinoma;

    机译:5-氨基乙酰乙酰酸;脱硅酸钠;光动力疗法;铁螯合;口腔舌鳞状细胞癌;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号